GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source Last Updated
PSICQUIC March 30, 2022
Displaying entries 3476 - 3500 of 4050 in total
Antibody Patient Onset (days) Symptom GlyTouCan ID Arbitrary Fluorescence Units (AFU) ▲
IgA Patient 1 22 moderate
G43534QA
753
IgA Patient 2 3 mild
G53168IY
755
IgG Patient 3 -180 mild
G68461PT
757
IgA Patient 4 12 mild
G96865DJ
757
IgA Patient 2 24 mild
G51872EK
759
IgM Patient 2 24 mild
G51175PR
763
IgG Patient 4 12 mild
G49108TO
764
IgM Patient 2 15 mild
G51872EK
765
IgM Patient 4 12 mild
G42666HT
765
IgA Patient 3 11 mild
G09482NW
771
IgA Patient 1 22 moderate
G17689EW
772
IgA Patient 2 15 mild
G51872EK
778
IgG Patient 2 24 mild
G60761LT
781
IgM Patient 2 15 mild
G81315DD
785
IgA Patient 2 3 mild
G69912LP
788
IgA Patient 4 12 mild
G47362BJ
790
IgM Patient 2 24 mild
G43648DB
791
IgG Patient 2 15 mild
G80587NA
794
IgA Patient 4 12 mild
G00057MO
800
IgA Patient 2 3 mild
G71142DF
805
IgM Patient 2 15 mild
G17140UR
806
IgM Patient 2 24 mild
G17140UR
806
IgA Patient 2 15 mild
G80587NA
807
IgM Patient 4 12 mild
G14988WV
808
IgA Patient 1 22 moderate
G49108TO
810

About Release Notes Help Feedback

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.1.0

Last updated: December 9, 2024